$RDGL

VIVOS INC

Insider trades

No enriched coverage for $RDGL in the last 7 days.

$17K
Weeks Brad Allan
0%
See all $RDGL insider activity →

RDGL sentiment & insider activity

Recent RDGL coverage spans insider activity and financial news.

In the last 30 days, RDGL insiders filed 4 SEC Form 4 transactions — 4 purchases ($17K) and no sales. The most active reporter was Weeks Brad Allan, President, with 3 filings.

What's driving RDGL

  • A small open-market insider buy is disclosed, but it is not a 10b5-1 plan and may signal confidence; however, the dollar value is modest.

    SEC EDGAR · Jul 22, 2026

  • An insider open-market purchase signals management confidence, but the disclosed dollar amount is small and lacks guidance or operational catalysts.

    SEC EDGAR · Jul 15, 2026

  • Insider open-market buying at a fixed low price can be a modest bullish signal, but the disclosed dollar amount is small and not a fundamental catalyst.

    SEC EDGAR · Jul 10, 2026

  • Vivos Inc. (RDGL) has reported positive results from its first human trial of RadioGel® therapy, which could be a breakthrough in cancer treatment. This development may lead to increased investor interest and a potential upward movement in stock price.

    Benzinga · Apr 28, 2025

alphai scores every news story that mentions RDGL with an AI model for sentiment and relevance, and aggregates insider trades from VIVOS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $RDGL

Score

Related tickers